Summary
Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Asthma
- The report reviews pipeline therapeutics for Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Asthma therapeutics and enlists all their major and minor projects
- The report assesses Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Asthma
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Asthma
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Companies Mentioned
4D Pharma Plc
AB Science SA
Abeome Corporation
Accolade Pharmaceuticals, LLC
Acorda Therapeutics, Inc.
Adamis Pharmaceuticals Corporation
Advinus Therapeutics Ltd.
Afferent Pharmaceuticals, Inc.
ALK-Abello A/S
Allergopharma GmbH & Co. KG
Almirall, S.A.
Amakem NV
Amgen Inc.
AnaptysBio, Inc.
Antisense Therapeutics Limited
Aquinox Pharmaceuticals Inc.
ARA Healthcare Pvt. Ltd.
Ario Pharma Ltd
ASIT biotech s.a.
Aslan Pharmaceuticals Pte. Ltd.
Astellas Pharma Inc.
AstraZeneca Plc
Asubio Pharma Co., Ltd.
Aurigene Discovery Technologies Limited
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Bioncotech Therapeutics S.L.
Biotec Pharmacon ASA
Boehringer Ingelheim GmbH
Caladrius Biosciences, Inc.
CalciMedica, Inc.
Carolus Therapeutics, Inc.
Cellceutix Corporation
Cellular Biomedicine Group, Inc.
Celon Pharma Sp. z o.o.
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp.
Circassia Pharmaceuticals Plc
Cognosci, Inc.
CSL Limited
Cumberland Pharmaceuticals, Inc.
Cytokinetics, Inc.
Daiichi Sankyo Company, Limited
Dynavax Technologies Corporation
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Foresee Pharmaceuticals, LLC
Fountain Biopharma Inc.
Genentech, Inc.
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd.
GliaCure Inc.
Griffin Discoveries BV
Hanmi Pharmaceuticals, Co. Ltd.
Hydra Biosciences, Inc.
iCeutica, Inc.
iCo Therapeutics Inc.
Infinity Pharmaceuticals, Inc.
INOXIA Lifesciences GmbH
Invion Limited
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Johnson & Johnson
Kineta, Inc.
Kissei Pharmaceutical Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Kyowa Hakko Kirin Co., Ltd.
Laboratoires Pierre Fabre SA
Lead Discovery Center GmbH
LegoChem Biosciences, Inc
Ligand Pharmaceuticals, Inc.
Lpath, Inc.
Marinomed Biotechnologie GmbH
MedImmune, LLC
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Mycenax Biotech Inc.
NAL Pharmaceuticals Ltd.
NeoPharm Co., Ltd.
Nostrum Pharmaceuticals, LLC
Novartis AG
Omeros Corporation
Ono Pharmaceutical Co., Ltd.
OPKO Health, Inc.
Orbis Biosciences, Inc.
Orion Oyj
Oxagen Limited
Palatin Technologies, Inc.
Panacea Biotec Limited
Panmira Pharmaceuticals, LLC.
Peptinnovate Limited
PharmaLundensis AB
Pharmaxis Limited
Plexxikon Inc.
Polyphor Ltd.
Promedior, Inc.
Protectimmun GmbH
Pulmagen Therapeutics LLP
Re-Pharm Limited
Regeneron Pharmaceuticals, Inc.
Respiratorius AB
ReveraGen BioPharma, Inc.
Rhizen Pharmaceuticals S.A.
Saje Pharma, LLC
SkyePharma Plc
Spring Bank Pharmaceuticals, Inc.
Stallergenes SAS
sterna biologicals Gmbh & Co KG
Sumitomo Dainippon Pharma Co., Ltd.
Sun Pharma Advanced Research Company Ltd.
Sunovion Pharmaceuticals Inc.
Swecure AB
Synovo GmbH
Syntrix Biosystems, Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
The International Biotechnology Center (IBC) Generium
Therabron Therapeutics, Inc.
Theraclone Sciences, Inc.
Theravance Biopharma, Inc.
Tolerys SA
UCB S.A.
United BioPharma, Inc.
Vectura Group Plc
Verona Pharma Plc
WhanIn Pharmaceutical Co., Ltd.
Xencor, Inc.
Yungjin Pharm. Co., Ltd.
Zambon Company S.p.A.
Ziarco Pharma Ltd
'
Table of Contents
Table of Contents 2
Introduction 9
Asthma Overview 10
Therapeutics Development 11
Asthma - Therapeutics under Development by Companies 13
Asthma - Therapeutics under Investigation by Universities/Institutes 25
Asthma - Pipeline Products Glance 27
Asthma - Products under Development by Companies 31
Asthma - Products under Investigation by Universities/Institutes 49
Asthma - Companies Involved in Therapeutics Development 51
Asthma - Therapeutics Assessment 180
Drug Profiles 216
Asthma - Recent Pipeline Updates 587
Asthma - Dormant Projects 689
Asthma - Discontinued Products 723
Asthma - Product Development Milestones 732
Appendix 741
List of Tables
Number of Products under Development for Asthma, H1 2016 41
Number of Products under Development for Asthma - Comparative Analysis, H1 2016 42
Number of Products under Development by Companies, H1 2016 44
Number of Products under Development by Companies, H1 2016 (Contd..1) 45
Number of Products under Development by Companies, H1 2016 (Contd..2) 46
Number of Products under Development by Companies, H1 2016 (Contd..3) 47
Number of Products under Development by Companies, H1 2016 (Contd..4) 48
Number of Products under Development by Companies, H1 2016 (Contd..5) 49
Number of Products under Development by Companies, H1 2016 (Contd..6) 50
Number of Products under Development by Companies, H1 2016 (Contd..7) 51
Number of Products under Development by Companies, H1 2016 (Contd..8) 52
Number of Products under Development by Companies, H1 2016 (Contd..9) 53
Number of Products under Development by Companies, H1 2016 (Contd..10) 54
Number of Products under Investigation by Universities/Institutes, H1 2016 56
Comparative Analysis by Late Stage Development, H1 2016 57
Comparative Analysis by Clinical Stage Development, H1 2016 58
Comparative Analysis by Early Stage Development, H1 2016 59
Comparative Analysis by Unknown Stage Development, H1 2016 60
Products under Development by Companies, H1 2016 61
Products under Development by Companies, H1 2016 (Contd..1) 62
Products under Development by Companies, H1 2016 (Contd..2) 63
Products under Development by Companies, H1 2016 (Contd..3) 64
Products under Development by Companies, H1 2016 (Contd..4) 65
Products under Development by Companies, H1 2016 (Contd..5) 66
Products under Development by Companies, H1 2016 (Contd..6) 67
Products under Development by Companies, H1 2016 (Contd..7) 68
Products under Development by Companies, H1 2016 (Contd..8) 69
Products under Development by Companies, H1 2016 (Contd..9) 70
Products under Development by Companies, H1 2016 (Contd..10) 71
Products under Development by Companies, H1 2016 (Contd..11) 72
Products under Development by Companies, H1 2016 (Contd..12) 73
Products under Development by Companies, H1 2016 (Contd..13) 74
Products under Development by Companies, H1 2016 (Contd..14) 75
Products under Development by Companies, H1 2016 (Contd..15) 76
Products under Development by Companies, H1 2016 (Contd..16) 77
Products under Development by Companies, H1 2016 (Contd..17) 78
Products under Investigation by Universities/Institutes, H1 2016 79
Products under Investigation by Universities/Institutes, H1 2016 (Contd..1) 80
Asthma - Pipeline by 4D Pharma Plc, H1 2016 81
Asthma - Pipeline by AB Science SA, H1 2016 82
Asthma - Pipeline by Abeome Corporation, H1 2016 83
Asthma - Pipeline by Accolade Pharmaceuticals, LLC, H1 2016 84
Asthma - Pipeline by Acorda Therapeutics, Inc., H1 2016 85
Asthma - Pipeline by Adamis Pharmaceuticals Corporation, H1 2016 86
Asthma - Pipeline by Advinus Therapeutics Ltd., H1 2016 87
Asthma - Pipeline by Afferent Pharmaceuticals, Inc., H1 2016 88
Asthma - Pipeline by ALK-Abello A/S, H1 2016 89
Asthma - Pipeline by Allergopharma GmbH & Co. KG, H1 2016 90
Asthma - Pipeline by Almirall, S.A., H1 2016 91
Asthma - Pipeline by Amakem NV, H1 2016 92
Asthma - Pipeline by Amgen Inc., H1 2016 93
Asthma - Pipeline by AnaptysBio, Inc., H1 2016 94
Asthma - Pipeline by Antisense Therapeutics Limited, H1 2016 95
Asthma - Pipeline by Aquinox Pharmaceuticals Inc., H1 2016 96
Asthma - Pipeline by ARA Healthcare Pvt. Ltd., H1 2016 97
Asthma - Pipeline by Ario Pharma Ltd, H1 2016 98
Asthma - Pipeline by ASIT biotech s.a., H1 2016 99
Asthma - Pipeline by Aslan Pharmaceuticals Pte. Ltd., H1 2016 100
Asthma - Pipeline by Astellas Pharma Inc., H1 2016 101
Asthma - Pipeline by AstraZeneca Plc, H1 2016 102
Asthma - Pipeline by Asubio Pharma Co., Ltd., H1 2016 103
Asthma - Pipeline by Aurigene Discovery Technologies Limited, H1 2016 104
Asthma - Pipeline by Axikin Pharmaceuticals, Inc., H1 2016 105
Asthma - Pipeline by Baxalta Incorporated, H1 2016 106
Asthma - Pipeline by Bioncotech Therapeutics S.L., H1 2016 107
Asthma - Pipeline by Biotec Pharmacon ASA, H1 2016 108
Asthma - Pipeline by Boehringer Ingelheim GmbH, H1 2016 109
Asthma - Pipeline by Caladrius Biosciences, Inc. , H1 2016 110
Asthma - Pipeline by CalciMedica, Inc., H1 2016 111
Asthma - Pipeline by Carolus Therapeutics, Inc., H1 2016 112
Asthma - Pipeline by Cellceutix Corporation, H1 2016 113
Asthma - Pipeline by Cellular Biomedicine Group, Inc., H1 2016 114
Asthma - Pipeline by Celon Pharma Sp. z o.o., H1 2016 115
Asthma - Pipeline by Chiesi Farmaceutici SpA, H1 2016 116
Asthma - Pipeline by Chong Kun Dang Pharmaceutical Corp., H1 2016 117
Asthma - Pipeline by Circassia Pharmaceuticals Plc, H1 2016 118
Asthma - Pipeline by Cognosci, Inc., H1 2016 119
Asthma - Pipeline by CSL Limited, H1 2016 120
Asthma - Pipeline by Cumberland Pharmaceuticals, Inc., H1 2016 121
Asthma - Pipeline by Cytokinetics, Inc., H1 2016 122
Asthma - Pipeline by Daiichi Sankyo Company, Limited, H1 2016 123
Asthma - Pipeline by Dynavax Technologies Corporation, H1 2016 124
Asthma - Pipeline by F. Hoffmann-La Roche Ltd., H1 2016 125
Asthma - Pipeline by Five Prime Therapeutics, Inc., H1 2016 126
Asthma - Pipeline by Foresee Pharmaceuticals, LLC, H1 2016 127
Asthma - Pipeline by Fountain Biopharma Inc., H1 2016 128
Asthma - Pipeline by Genentech, Inc., H1 2016 129
Asthma - Pipeline by GlaxoSmithKline Plc, H1 2016 130
Asthma - Pipeline by Glenmark Pharmaceuticals Ltd., H1 2016 131
Asthma - Pipeline by GliaCure Inc., H1 2016 132
Asthma - Pipeline by Griffin Discoveries BV, H1 2016 133
Asthma - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2016 134
Asthma - Pipeline by Hydra Biosciences, Inc., H1 2016 135
Asthma - Pipeline by iCeutica, Inc., H1 2016 136
Asthma - Pipeline by iCo Therapeutics Inc., H1 2016 137
Asthma - Pipeline by Infinity Pharmaceuticals, Inc., H1 2016 138
Asthma - Pipeline by INOXIA Lifesciences GmbH, H1 2016 139
Asthma - Pipeline by Invion Limited, H1 2016 140
Asthma - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H1 2016 141
Asthma - Pipeline by Johnson & Johnson, H1 2016 142
Asthma - Pipeline by Kineta, Inc., H1 2016 143
Asthma - Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2016 144
Asthma - Pipeline by Kolltan Pharmaceuticals, Inc., H1 2016 145
Asthma - Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2016 146
Asthma - Pipeline by Laboratoires Pierre Fabre SA, H1 2016 147
Asthma - Pipeline by Lead Discovery Center GmbH, H1 2016 148
Asthma - Pipeline by LegoChem Biosciences, Inc, H1 2016 149
Asthma - Pipeline by Ligand Pharmaceuticals, Inc., H1 2016 150
Asthma - Pipeline by Lpath, Inc., H1 2016 151
Asthma - Pipeline by Marinomed Biotechnologie GmbH, H1 2016 152
Asthma - Pipeline by MedImmune, LLC, H1 2016 153
Asthma - Pipeline by Merck & Co., Inc., H1 2016 154
Asthma - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2016 155
Asthma - Pipeline by Mycenax Biotech Inc., H1 2016 156
Asthma - Pipeline by NAL Pharmaceuticals Ltd., H1 2016 157
Asthma - Pipeline by NeoPharm Co., Ltd., H1 2016 158
Asthma - Pipeline by Nostrum Pharmaceuticals, LLC, H1 2016 159
Asthma - Pipeline by Novartis AG, H1 2016 160
Asthma - Pipeline by Omeros Corporation, H1 2016 161
Asthma - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2016 162
Asthma - Pipeline by OPKO Health, Inc., H1 2016 163
Asthma - Pipeline by Orbis Biosciences, Inc., H1 2016 164
Asthma - Pipeline by Orion Oyj, H1 2016 165
Asthma - Pipeline by Oxagen Limited, H1 2016 166
Asthma - Pipeline by Palatin Technologies, Inc., H1 2016 167
Asthma - Pipeline by Panacea Biotec Limited, H1 2016 168
Asthma - Pipeline by Panmira Pharmaceuticals, LLC., H1 2016 169
Asthma - Pipeline by Peptinnovate Limited, H1 2016 170
Asthma - Pipeline by PharmaLundensis AB, H1 2016 171
Asthma - Pipeline by Pharmaxis Limited, H1 2016 172
Asthma - Pipeline by Plexxikon Inc., H1 2016 173
Asthma - Pipeline by Polyphor Ltd., H1 2016 174
Asthma - Pipeline by Promedior, Inc., H1 2016 175
Asthma - Pipeline by Protectimmun GmbH, H1 2016 176
Asthma - Pipeline by Pulmagen Therapeutics LLP, H1 2016 177
Asthma - Pipeline by Re-Pharm Limited, H1 2016 178
Asthma - Pipeline by Regeneron Pharmaceuticals, Inc., H1 2016 179
Asthma - Pipeline by Respiratorius AB, H1 2016 180
Asthma - Pipeline by ReveraGen BioPharma, Inc., H1 2016 181
Asthma - Pipeline by Rhizen Pharmaceuticals S.A., H1 2016 182
Asthma - Pipeline by Saje Pharma, LLC, H1 2016 183
Asthma - Pipeline by SkyePharma Plc, H1 2016 184
Asthma - Pipeline by Spring Bank Pharmaceuticals, Inc., H1 2016 185
Asthma - Pipeline by Stallergenes SAS, H1 2016 186
Asthma - Pipeline by sterna biologicals Gmbh & Co KG, H1 2016 187
Asthma - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H1 2016 188
Asthma - Pipeline by Sun Pharma Advanced Research Company Ltd., H1 2016 189
Asthma - Pipeline by Sunovion Pharmaceuticals Inc., H1 2016 190
Asthma - Pipeline by Swecure AB, H1 2016 191
Asthma - Pipeline by Synovo GmbH, H1 2016 192
Asthma - Pipeline by Syntrix Biosystems, Inc., H1 2016 193
Asthma - Pipeline by Takeda Pharmaceutical Company Limited, H1 2016 194
Asthma - Pipeline by Teva Pharmaceutical Industries Ltd., H1 2016 195
Asthma - Pipeline by The International Biotechnology Center (IBC) Generium, H1 2016 196
Asthma - Pipeline by Therabron Therapeutics, Inc., H1 2016 197
Asthma - Pipeline by Theraclone Sciences, Inc., H1 2016 198
Asthma - Pipeline by Theravance Biopharma, Inc., H1 2016 199
Asthma - Pipeline by Tolerys SA, H1 2016 200
Asthma - Pipeline by UCB S.A., H1 2016 201
Asthma - Pipeline by United BioPharma, Inc., H1 2016 202
Asthma - Pipeline by Vectura Group Plc, H1 2016 203
Asthma - Pipeline by Verona Pharma Plc, H1 2016 204
Asthma - Pipeline by WhanIn Pharmaceutical Co., Ltd., H1 2016 205
Asthma - Pipeline by Xencor, Inc., H1 2016 206
Asthma - Pipeline by Yungjin Pharm. Co., Ltd., H1 2016 207
Asthma - Pipeline by Zambon Company S.p.A., H1 2016 208
Asthma - Pipeline by Ziarco Pharma Ltd, H1 2016 209
Assessment by Monotherapy Products, H1 2016 210
Assessment by Combination Products, H1 2016 211
Number of Products by Stage and Target, H1 2016 213
Number of Products by Stage and Mechanism of Action, H1 2016 232
Number of Products by Stage and Route of Administration, H1 2016 243
Number of Products by Stage and Molecule Type, H1 2016 245
Asthma Therapeutics - Recent Pipeline Updates, H1 2016 617
Asthma - Dormant Projects, H1 2016 719
Asthma - Dormant Projects (Contd..1), H1 2016 720
Asthma - Dormant Projects (Contd..2), H1 2016 721
Asthma - Dormant Projects (Contd..3), H1 2016 722
Asthma - Dormant Projects (Contd..4), H1 2016 723
Asthma - Dormant Projects (Contd..5), H1 2016 724
Asthma - Dormant Projects (Contd..6), H1 2016 725
Asthma - Dormant Projects (Contd..7), H1 2016 726
Asthma - Dormant Projects (Contd..8), H1 2016 727
Asthma - Dormant Projects (Contd..9), H1 2016 728
Asthma - Dormant Projects (Contd..10), H1 2016 729
Asthma - Dormant Projects (Contd..11), H1 2016 730
Asthma - Dormant Projects (Contd..12), H1 2016 731
Asthma - Dormant Projects (Contd..13), H1 2016 732
Asthma - Dormant Projects (Contd..14), H1 2016 733
Asthma - Dormant Projects (Contd..15), H1 2016 734
Asthma - Dormant Projects (Contd..16), H1 2016 735
Asthma - Dormant Projects (Contd..17), H1 2016 736
Asthma - Dormant Projects (Contd..18), H1 2016 737
Asthma - Dormant Projects (Contd..19), H1 2016 738
Asthma - Dormant Projects (Contd..20), H1 2016 739
Asthma - Dormant Projects (Contd..21), H1 2016 740
Asthma - Dormant Projects (Contd..22), H1 2016 741
Asthma - Dormant Projects (Contd..23), H1 2016 742
Asthma - Dormant Projects (Contd..24), H1 2016 743
Asthma - Dormant Projects (Contd..25), H1 2016 744
Asthma - Dormant Projects (Contd..26), H1 2016 745
Asthma - Dormant Projects (Contd..27), H1 2016 746
Asthma - Dormant Projects (Contd..28), H1 2016 747
Asthma - Dormant Projects (Contd..29), H1 2016 748
Asthma - Dormant Projects (Contd..30), H1 2016 749
Asthma - Dormant Projects (Contd..31), H1 2016 750
Asthma - Dormant Projects (Contd..32), H1 2016 751
Asthma - Dormant Projects (Contd..33), H1 2016 752
Asthma - Discontinued Products, H1 2016 753
Asthma - Discontinued Products (Contd..1), H1 2016 754
Asthma - Discontinued Products (Contd..2), H1 2016 755
Asthma - Discontinued Products (Contd..3), H1 2016 756
Asthma - Discontinued Products (Contd..4), H1 2016 757
Asthma - Discontinued Products (Contd..5), H1 2016 758
Asthma - Discontinued Products (Contd..6), H1 2016 759
Asthma - Discontinued Products (Contd..7), H1 2016 760
Asthma - Discontinued Products (Contd..8), H1 2016 761
List of Figures
Number of Products under Development for Asthma, H1 2016 41
Number of Products under Development for Asthma - Comparative Analysis, H1 2016 42
Number of Products under Development by Companies, H1 2016 43
Number of Products under Investigation by Universities/Institutes, H1 2016 55
Comparative Analysis by Late Stage Development, H1 2016 57
Comparative Analysis by Clinical Stage Development, H1 2016 58
Comparative Analysis by Early Stage Products, H1 2016 59
Assessment by Monotherapy Products, H1 2016 210
Assessment by Combination Products, H1 2016 211
Number of Products by Top 10 Targets, H1 2016 212
Number of Products by Stage and Top 10 Targets, H1 2016 212
Number of Products by Top 10 Mechanism of Actions, H1 2016 231
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 231
Number of Products by Top 10 Routes of Administration, H1 2016 242
Number of Products by Stage and Top 10 Routes of Administration, H1 2016 242
Number of Products by Top 10 Molecule Types, H1 2016 244
Number of Products by Stage and Top 10 Molecule Types, H1 2016 244
